Methamphetamine toxicity prevented by activated charcoal in a mouse model

Area of Science:

• Toxicology
• Pharmacology
• Emergency Medicine

Background:

• Methamphetamine hydrochloride (HCI) is a potent stimulant with significant toxicity risks.
• Oral ingestion of methamphetamine HCI can lead to severe health consequences.
• Effective interventions for acute methamphetamine toxicity are crucial.

Purpose of the Study:

• To evaluate the efficacy of activated charcoal in mitigating oral methamphetamine HCI toxicity.
• To assess the impact of activated charcoal on the onset of toxic symptoms and mortality rates.

Main Methods:

• A randomized, prospective, controlled animal study was conducted using CD-1 male mice.
• Mice received a lethal dose of methamphetamine HCI (100 mg/kg) orally.
• Activated charcoal (1 g/kg) or a water control was administered within one minute of methamphetamine exposure.

Main Results:

• Activated charcoal significantly delayed the onset of methamphetamine-induced symptoms, including piloerection, agitation, and tremor (P < .002).
• Early mortality at 1 and 24 hours was significantly reduced in the activated charcoal group compared to controls (P < .003 and P < .05, respectively).
• No significant difference in mortality was observed between groups at 48 hours.

Conclusions:

• A single dose of activated charcoal administered post-oral methamphetamine ingestion can delay toxicity onset and decrease early mortality in mice.
• Activated charcoal demonstrates potential as an early intervention for acute oral methamphetamine toxicity.
• The study suggests activated charcoal's benefit is primarily in reducing immediate and short-term mortality, not long-term survival.